跳转至内容
Merck
CN

MAB10216

抗黄病毒组抗原抗体,克隆D1-4G2-4-15

ascites fluid, clone D1-4G2-4-15, Chemicon®

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

eCl@ss:
32160702
UNSPSC Code:
12352203
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


biological source

mouse

antibody form

ascites fluid

antibody product type

primary antibodies

clone

D1-4G2-4-15, monoclonal

species reactivity

human

manufacturer/tradename

Chemicon®

technique(s)

immunofluorescence: suitable

isotype

IgG1, IgG2a

shipped in

dry ice

General description

黄病毒科的病毒是人类和兽医学中重要的节肢动物传播的病毒。它们通过蚊子和蜱传播,通常在自然界中维持在传播周期中。它们在人类中产生广泛的临床反应,从无症状的感染到暴发性脑炎或出血热。已知存在近60种黄病毒,但许多尚未证明会引起人类疾病。

Immunogen

登革热病毒2型抗原

Application

&已发表抗黄病毒组抗原抗体,克隆D1-4G2-4-15可检测黄病毒组抗原水平,&经验证可用于IF。

Biochem/physiol Actions

识别黄病毒组特异性抗原(登革热病毒、西尼罗河病毒、日本乙型脑炎、黄热病病毒、寨卡病毒等)。它与蛋白E结构域II末端的融合环结合。

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany


Still not finding the right product?

试用我们的 产品选型工具 工具缩小选择范围


存储类别

10 - Combustible liquids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable



分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Natalie A Prow et al.
NPJ vaccines, 5, 44-44 (2020-06-19)
The Sementis Copenhagen Vector (SCV) is a new vaccinia virus-derived, multiplication-defective, vaccine technology assessed herein in non-human primates. Indian rhesus macaques (Macaca mulatta) were vaccinated with a multi-pathogen recombinant SCV vaccine encoding the structural polyproteins of both Zika virus (ZIKV)
Jacob T Beaver et al.
Human vaccines & immunotherapeutics, 16(9), 2092-2108 (2020-08-08)
A severe consequence of adult Zika virus (ZIKV) infection is Guillain-Barré Syndrome (GBS), where autoreactive antibodies attack peripheral and central nervous systems (CNS) resulting in neuro-ocular pathology and fatal complications. During virally induced GBS, autoimmune brain demyelination and macular degeneration
Sheila Cabezas et al.
Journal of virology, 92(14) (2018-05-11)
Severe dengue virus (DENV) infection is associated with overactivity of the complement alternative pathway (AP) in patient studies. Here, the molecular changes in components of the AP during DENV infection in vitro were investigated. mRNA for factor H (FH), a